Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Expert Review of Clinical Immunology|May 26, 2017
Treatment of adult-onset still's disease: up to dateDae Hyun YooExpert Review of Clinical Immunology|June 26, 2014
The rise of biosimilars: potential benefits and drawbacks in rheumatoid arthritisDae Hyun YooExpert Opinion on Biological Therapy|August 6, 2019
Biologics for the treatment of adult-onset still's diseaseDae Hyun YooJournal of Comparative Effectiveness Research|November 28, 2017
Comparative effectiveness of the biosimilar CT-P13Dae Hyun YooExpert Review of Clinical Immunology|June 3, 2017
CT-P13 in the treatment of rheumatoid arthritisDae Hyun YooJournal of Korean Medical Science|December 21, 2006
Idiopathic palmar fasciitis with polyarthritis syndromeYoon-Kyoung Sung, Moon-Hyang Park, Dae-Hyun YooExpert Review of Clinical Immunology|September 24, 2015
Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal productDae Hyun Yoo, Choongseob Oh, SeungSuh Hong, et al.Journal of Korean Medical Science|June 17, 2006
Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndromeJin-Wuk Hur, Chang-Woo Lee, Dae-Hyun YooExpert Review of Clinical Immunology|September 24, 2015
Comparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy subjects: a randomized, double-blind, three-arm, parallel-group, single-dose, Phase I studyWon Park, Sang Joon Lee, Jihye Yun, et al.Journal of Clinical Medicine|March 3, 2021
Different Features of Interleukin-37 and Interleukin-18 as Disase Activity Markers of Adult-Onset Still's DiseaseSeoung Wan Nam, SuMan Kang, Jun Hyeok Lee, et al.Pageof 15